In a new experimental study, scientists from Juntendo University in collaboration with researchers from the University of Tokyo have developed an adeno-associated virus (AAV) vector-mediated ...

The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a ...

The Adeno Associated Virus Vector Manufacturing market, valued at USD 1,148.4 million in 2024, is expected to register robust revenue CAGR of 19.6%. Request free copy ...

4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform ...

Belief BioMed (BBM) and Takeda China have announced the receipt of China’s NMPA approval for BBM-H901for treating haemophilia ...

The combination of synchronous experimental process development and digital twin core model development is among the first of its kind.

Its maker, Sarepta Therapeutics, hasn’t ruled out the possibility that the treatment, which uses an adeno-associated virus vector to deliver its therapeutic gene payload, may have contributed to ...